Individual telomere lengths in chronic myeloid leukemia

Neoplasia

Volumn 11, Issue 11, 2009, Pages 1146-1154

  Samassekou, Oumar ^a   Ntwari, Aimé ^a   Hébert, Josée ^b,c   Yan, Ju ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PEPTIDE NUCLEIC ACID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW CULTURE; CELL SIZE; CHROMOSOME ABERRATION; CHROMOSOME ARM; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DNA EXTRACTION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN SITU HYBRIDIZATION; KARYOTYPE; LEUKEMIA CELL; MALE; METAPHASE; PRIORITY JOURNAL; RESTRICTION FRAGMENT; TELOMERE;

EID: 70350728531     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.09836     Document Type: Article

References (47)

1. Lee HW, Blasco MA, Gottlieb GJ, Horner JW II, Greider CW, and DePinho RA (1998). Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574.
2. de Lange T (2005). Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19, 2100-2110.
3. Sfeir AJ, Chai W, Shay JW, and Wright WE (2005). Telomere-end processing the terminal nucleotides of human chromosomes. Mol Cell 18, 131-138. (Pubitemid 40444654)
4. Lingner J, Cooper JP, and Cech TR (1995). Telomerase and DNA end replication: no longer a lagging strand problem? Science 269, 1533-1534.
5. Greider CW and Blackburn EH (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413.
6. Lansdorp PM(2008). Telomeres, stem cells, and hematology. Blood 111, 1759-1766.
7. McClintock B (1939). The behavior in successive nuclear divisions of a chromosome broken at meiosis. Proc Natl Acad Sci USA 25, 405-416.
8. Muller HJ (1938). The re-making of chromosomes. Collecting Net, Woods Hole 13, 181-198.
9. Harley CB, Futcher AB, and Greider CW (1990). Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460. (Pubitemid 120014963)
10. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, and Shay JW (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
11. Rowley JD (1973). Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290-293.
12. Quintas-Cardama A and Cortes J (2009). Molecular biology of bcr-abl1-positive chronic myeloid leukemia. Blood 113, 1619-1630.
13. Boultwood J, Fidler C, Shepherd P, Watkins F, Snowball J, Haynes S, Kusec R, Gaiger A, Littlewood TJ, Peniket AJ, et al. (1999). Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. Am J Hematol 61, 5-9. (Pubitemid 29218170)
14. Brummendorf TH, Holyoake TL, Rufer N, Barnett MJ, Schulzer M, Eaves CJ, Eaves AC, and Lansdorp PM (2000). Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood 95, 1883-1890. (Pubitemid 30151622)
15. Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, and Toyama K (1997). Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia 11, 190-194. (Pubitemid 27085160)
16. Martens UM, Zijlmans JM, Poon SS, Dragowska W, Yui J, Chavez EA, Ward RK, and Lansdorp PM (1998). Short telomeres on human chromosome 17p. Nat Genet 18, 76-80.
17. Radich JP (2007). The biology of CML blast crisis. Hematology Am Soc Hematol Educ Program 2007, 384-391.
18. Spurbeck JL, Zinsmeister AR, Meyer KJ, and Jalal SM (1996). Dynamics of chromosome spreading. Am J Med Genet 61, 387-393.
19. Yan J, Chen BZ, Bouchard EF, and Drouin R (2004). The labeling efficiency of human telomeres is increased by double-strand PRINS. Chromosoma 113, 204-209. (Pubitemid 39409790)
20. Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska V, Little MT, Dirks RW, Raap AK, and Tanke HJ (1996). Heterogeneity in telomere length of human chromosomes. Hum Mol Genet 5, 685-691. (Pubitemid 26141285)
21. Dewald G, Stallard R, Al Saadi A, Arnold S, Bader PI, Blough R, Chen K, Elejalde BR, Harris CJ, Higgins RR, et al. (1998). A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes. Am J Med Genet 76, 318-326. (Pubitemid 28136105)
22. Perner S, Brüderlein S, Hasel C, Waibel I, Holdenried A, Ciloglu N, Chopurian H, Nielsen KV, Plesch A, Högel J, et al. (2003). Quantifying telomere lengths of human individual chromosome arms by centromere-calibrated fluorescence in situ hybridization and digital imaging. Am J Pathol 163, 1751-1756. (Pubitemid 37310006)
23. Sakoff JA, De Waal E, Garg MB, Denham J, Scorgie FE, Enno A, Lincz LF, and Ackland SP (2002). Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole blood. Leuk Lymphoma 43, 2017-2020.
24. Yamada O, Kawauchi K, Akiyama M, Ozaki K, Motoji T, Adachi T, and Aikawa E (2008). Leukemic cells with increased telomerase activity exhibit resistance to imatinib. Leuk Lymphoma 49, 1168-1177. (Pubitemid 351943264)
25. Ohyashiki K, Ohyashiki JH, Fujimura T, Kawakubo K, Shimamoto T, Saito M, Nakazawa S, andToyamaK (1994). Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capability. Cancer Genet Cytogenet 78, 64-67. (Pubitemid 24378607)
26. Terasaki Y, Okumura H, Ohtake S, and Nakao S (2002). Accelerated telomere length shortening in granulocytes: a diagnostic marker for myeloproliferative diseases. Exp Hematol 30, 1399-1404. (Pubitemid 35449796)
27. Engelhardt M, Ozkaynak MF, Drullinsky P, Sandoval C, Tugal O, Jayabose S, and Moore MA (1998). Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 12, 13-24. (Pubitemid 28043759)
28. Martens UM, Chavez EA, Poon SS, Schmoor C, and Lansdorp PM (2000). Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res 256, 291-299. (Pubitemid 30211191)
29. Graakjaer J, Bischoff C, Korsholm L, Holstebroe S, Vach W, Bohr VA, Christensen K, and Kolvraa S (2003). The pattern of chromosome-specific variations in telomere length in humans is determined by inherited, telomere-near factors and is maintained throughout life. Mech Ageing Dev 124, 629-640.
30. Zheng YL, Loffredo CA, Shields PG, and Selim S (2009). Chromosome 9 arm- specific telomere length and breast cancer risk. Carcinogenesis 30, 1380-1386.
31. Rashid-Kolvear F, Pintilie M, and Done SJ (2007). Telomere length on chromosome 17q shortens more than global telomere length in the development of breast cancer. Neoplasia 9, 265-270. (Pubitemid 46608293)
32. Mitelman F (1993). The cytogenetic scenario of chronic myeloid leukemia. Leuk Lymphoma 11 (Suppl 1), 11-15. (Pubitemid 23274129)
33. Mitelman F, Levan G, Nilsson PG, and Brandt L (1976). Non-random karyotypic evolution in chronic myeloid leukemia. Int J Cancer 18, 24-30.
34. Keller G, Brassat U, Braig M, Heim D, Wege H, and Brummendorf TH (2009). Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy. Hematol Oncol 27, 123-129.
35. Zou Y, Sfeir A, Gryaznov SM, Shay JW, and Wright WE (2004). Does a sentinel or a subset of short telomeres determine replicative senescence? Mol Biol Cell 15, 3709-3718.
36. Krejci K, Stentoft J, and Koch J (1999). Molecular cytogenetics investigation of the telomeres in a case of Philadelphia positive B-ALL with a single telomere expansion. Neoplasia 1, 492-497.
37. Perrem K, Colgin LM, Neumann AA, Yeager TR, and Reddel RR (2001). Coexistence of alternative lengthening of telomeres and telomerase in hTERTtransfected GM847 cells. Mol Cell Biol 21, 3862-3875. (Pubitemid 32476449)
38. Johansson B, Fioretos T, and Mitelman F (2002). Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107, 76-94. (Pubitemid 34264171)
39. Murray-Zmijewski F, Slee EA, and Lu X (2008). A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 9, 702-712.
40. Ashur-Fabian O, Adamsky K, Trakhtenbrot L, Cohen Y, Raanani P, Hardan I, Nagler A, Rechavi G, and Amariglio N (2007). Apaf1 in chronic myelogenous leukemia (CML) progression: reduced Apaf1 expression is correlated with a H179R p53 mutation during clinical blast crisis. Cell Cycle 6, 589-594. (Pubitemid 46440433)
41. Ahuja H, Bar-Eli M, Advani SH, Benchimol S, and Cline MJ (1989). Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proc Natl Acad Sci USA 86, 6783-6787. (Pubitemid 19236343)
42. Feinstein E, Cimino G, Gale RP, Alimena G, Berthier R, Kishi K, Goldman J, Zaccaria A, Berrebi A, and Canaani E (1991). P53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci USA 88, 6293-6297. (Pubitemid 21914932)
43. Hemann MT, Strong MA, Hao LY, and Greider CW (2001). The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67-77.
44. Morrish TA and Greider CW (2009). Short telomeres initiate telomere recombination in primary and tumor cells. PLoS Genet 5, e1000357.
45. Londono-Vallejo JA, Der-Sarkissian H, Cazes L, Bacchetti S, and Reddel RR (2004). Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Res 64, 2324-2327. (Pubitemid 38523881)
46. Gonzalo S, Jaco I, Fraga MF, Chen T, Li E, Esteller M, and Blasco MA (2006). DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 8, 416-424.
47. Vera E, Canela A, Fraga MF, Esteller M, and Blasco MA (2008). Epigenetic regulation of telomeres in human cancer. Oncogene 27, 6817-6833.